Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers

Beta-blocker therapies for cardiovascular comorbidities are often withheld in patients with chronic obstructive pulmonary disease (COPD) due to potential adverse effects on airway obstruction. We carried out a...

Source: Respiratory Research - October 22, 2021 Category: Respiratory Medicine Authors: Kenneth R. Chapman, Robert A. Wise, Benjamin M. Scirica, Deepak L. Bhatt, Sami Z. Daoud, Dan Lythgoe and Esther Garcia Gil Tags: Research Source Type: research